vs
Side-by-side financial comparison of Bio-Techne (TECH) and WillScot Holdings Corp (WSC). Click either name above to swap in a different company.
WillScot Holdings Corp is the larger business by last-quarter revenue ($566.0M vs $295.9M, roughly 1.9× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -33.1%, a 45.9% gap on every dollar of revenue. On growth, WillScot Holdings Corp posted the faster year-over-year revenue change (-6.1% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs -1.8%).
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
WillScot Holdings Corp is a leading provider of modular space solutions and portable storage services across North America. It serves a wide range of sectors including construction, commercial development, education, healthcare, government projects, and special events, offering flexible, scalable temporary and semi-permanent space solutions tailored to diverse client needs.
TECH vs WSC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $566.0M |
| Net Profit | $38.0M | $-187.3M |
| Gross Margin | 64.6% | 50.4% |
| Operating Margin | 18.4% | -32.5% |
| Net Margin | 12.8% | -33.1% |
| Revenue YoY | -6.4% | -6.1% |
| Net Profit YoY | 68.3% | -310.0% |
| EPS (diluted) | $0.24 | $-1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $295.9M | $566.0M | ||
| Q3 25 | — | $566.8M | ||
| Q2 25 | $317.0M | $589.1M | ||
| Q1 25 | $316.2M | $559.6M | ||
| Q4 24 | $297.0M | $602.5M | ||
| Q3 24 | $289.5M | $601.4M | ||
| Q2 24 | $306.1M | $604.6M | ||
| Q1 24 | $303.4M | $587.2M |
| Q4 25 | $38.0M | $-187.3M | ||
| Q3 25 | — | $43.3M | ||
| Q2 25 | $-17.7M | $47.9M | ||
| Q1 25 | $22.6M | $43.1M | ||
| Q4 24 | $34.9M | $89.2M | ||
| Q3 24 | $33.6M | $-70.5M | ||
| Q2 24 | $40.6M | $-46.9M | ||
| Q1 24 | $49.1M | $56.2M |
| Q4 25 | 64.6% | 50.4% | ||
| Q3 25 | — | 49.7% | ||
| Q2 25 | 62.7% | 50.3% | ||
| Q1 25 | 67.9% | 53.7% | ||
| Q4 24 | 65.3% | 55.8% | ||
| Q3 24 | 63.2% | 53.5% | ||
| Q2 24 | 66.4% | 54.1% | ||
| Q1 24 | 67.4% | 54.0% |
| Q4 25 | 18.4% | -32.5% | ||
| Q3 25 | — | 21.0% | ||
| Q2 25 | -7.5% | 21.5% | ||
| Q1 25 | 12.2% | 21.3% | ||
| Q4 24 | 16.0% | 28.9% | ||
| Q3 24 | 13.8% | -5.9% | ||
| Q2 24 | 15.0% | -0.9% | ||
| Q1 24 | 22.1% | 22.1% |
| Q4 25 | 12.8% | -33.1% | ||
| Q3 25 | — | 7.6% | ||
| Q2 25 | -5.6% | 8.1% | ||
| Q1 25 | 7.1% | 7.7% | ||
| Q4 24 | 11.7% | 14.8% | ||
| Q3 24 | 11.6% | -11.7% | ||
| Q2 24 | 13.3% | -7.7% | ||
| Q1 24 | 16.2% | 9.6% |
| Q4 25 | $0.24 | $-1.02 | ||
| Q3 25 | — | $0.24 | ||
| Q2 25 | $-0.11 | $0.26 | ||
| Q1 25 | $0.14 | $0.23 | ||
| Q4 24 | $0.22 | $0.48 | ||
| Q3 24 | $0.21 | $-0.37 | ||
| Q2 24 | $0.26 | $-0.25 | ||
| Q1 24 | $0.31 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $172.9M | $14.6M |
| Total DebtLower is stronger | $260.0M | $3.6B |
| Stockholders' EquityBook value | $2.0B | $856.3M |
| Total Assets | $2.5B | $5.8B |
| Debt / EquityLower = less leverage | 0.13× | 4.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $172.9M | $14.6M | ||
| Q3 25 | — | $14.8M | ||
| Q2 25 | $162.2M | $12.8M | ||
| Q1 25 | $140.7M | $10.7M | ||
| Q4 24 | $177.5M | $9.0M | ||
| Q3 24 | $187.5M | $11.0M | ||
| Q2 24 | $152.9M | $5.9M | ||
| Q1 24 | $145.3M | $13.1M |
| Q4 25 | $260.0M | $3.6B | ||
| Q3 25 | — | $3.6B | ||
| Q2 25 | $346.0M | $3.7B | ||
| Q1 25 | $330.0M | $3.6B | ||
| Q4 24 | $300.0M | $3.7B | ||
| Q3 24 | $300.0M | $3.6B | ||
| Q2 24 | $319.0M | $3.5B | ||
| Q1 24 | $389.0M | $3.5B |
| Q4 25 | $2.0B | $856.3M | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | $1.9B | $1.0B | ||
| Q1 25 | $2.0B | $1.0B | ||
| Q4 24 | $2.1B | $1.0B | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.1B | $1.2B | ||
| Q1 24 | $2.0B | $1.3B |
| Q4 25 | $2.5B | $5.8B | ||
| Q3 25 | — | $6.1B | ||
| Q2 25 | $2.6B | $6.1B | ||
| Q1 25 | $2.6B | $6.0B | ||
| Q4 24 | $2.7B | $6.0B | ||
| Q3 24 | $2.7B | $6.0B | ||
| Q2 24 | $2.7B | $6.0B | ||
| Q1 24 | $2.7B | $6.2B |
| Q4 25 | 0.13× | 4.15× | ||
| Q3 25 | — | 3.39× | ||
| Q2 25 | 0.18× | 3.55× | ||
| Q1 25 | 0.16× | 3.56× | ||
| Q4 24 | 0.14× | 3.62× | ||
| Q3 24 | 0.14× | 3.42× | ||
| Q2 24 | 0.15× | 2.88× | ||
| Q1 24 | 0.19× | 2.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $158.9M |
| Free Cash FlowOCF − Capex | — | $149.7M |
| FCF MarginFCF / Revenue | — | 26.5% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $737.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $158.9M | ||
| Q3 25 | — | $191.2M | ||
| Q2 25 | $98.2M | $205.3M | ||
| Q1 25 | $41.1M | $206.6M | ||
| Q4 24 | $84.3M | $178.9M | ||
| Q3 24 | $63.9M | $-1.6M | ||
| Q2 24 | $75.5M | $175.6M | ||
| Q1 24 | $81.0M | $208.7M |
| Q4 25 | — | $149.7M | ||
| Q3 25 | — | $186.9M | ||
| Q2 25 | $93.3M | $199.0M | ||
| Q1 25 | $31.0M | $202.0M | ||
| Q4 24 | $77.5M | $176.6M | ||
| Q3 24 | $54.7M | $-4.9M | ||
| Q2 24 | $57.5M | $169.4M | ||
| Q1 24 | $64.5M | $202.1M |
| Q4 25 | — | 26.5% | ||
| Q3 25 | — | 33.0% | ||
| Q2 25 | 29.4% | 33.8% | ||
| Q1 25 | 9.8% | 36.1% | ||
| Q4 24 | 26.1% | 29.3% | ||
| Q3 24 | 18.9% | -0.8% | ||
| Q2 24 | 18.8% | 28.0% | ||
| Q1 24 | 21.3% | 34.4% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | 1.5% | 1.1% | ||
| Q1 25 | 3.2% | 0.8% | ||
| Q4 24 | 2.3% | 0.4% | ||
| Q3 24 | 3.2% | 0.6% | ||
| Q2 24 | 5.9% | 1.0% | ||
| Q1 24 | 5.4% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.41× | ||
| Q2 25 | — | 4.28× | ||
| Q1 25 | 1.82× | 4.80× | ||
| Q4 24 | 2.42× | 2.01× | ||
| Q3 24 | 1.90× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.65× | 3.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
WSC
| Modular Space Leasing | $249.8M | 44% |
| Value Added Product And Services | $101.0M | 18% |
| Portable Storage Leasing | $83.0M | 15% |
| Delivery Revenue | $48.2M | 9% |
| Installation Revenue | $45.0M | 8% |
| Rental Units | $19.7M | 3% |
| New Units | $15.5M | 3% |
| Value Added Services | $10.3M | 2% |
| Other Leasing Related Products And Services | $3.8M | 1% |
